Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Natasha Barrow



Latest From Natasha Barrow

‘Deep Concerns’ Raised Over EHDS Regulation By Medtech Industry

Health stakeholder organizations including COCIR and MedTech Europe have issued a press statement outlining 10 fundamental issues with the European Health Data Space Regulation. The groups’ areas of focus include: legal clarity and member state harmonization; coordination and cooperation with existing infrastructures and stakeholders; and training.

EU Europe

NICE Recommends Endoscopic Sleeve Gastroplasty To Treat Obesity

NICE has recommended endoscopic sleeve gastroplasty for the treatment of obesity in adults.

EU Europe

Experts Press For New Artificial Intelligence Regulatory Approaches

Rigid regulations are delaying patient access to life-saving technology and preventing AI innovation in the EU, researchers say. A new paper from the publishers of Nature gives concrete proposals for how to adapt EU regulatory approaches to support innovative health tech.

EU Europe

UK Offers £10M Funding To Eight Medtech Innovators

The Innovative Device Access Pathway pilot has launched in the UK with eight new promising medical technologies. The cohort is overwhelmingly diagnostic-focused, with innovative testing for Alzheimer’s, stroke, and liver cancer, amongst others.

EU Europe

EU Artificial Intelligence Final Text Confirmed By Parliament Committees

The “first AI Act in the world” was adopted with an overwhelming majority by European Parliament Committees IMCO and LIBE.

EU Europe

Progress Made With HTA Regulation Implementation Plan

Implementing acts for Joint Clinical Assessments and exchange of information with the EMA were on the agenda of this month’s Member States Coordination Group on HTA meeting. The discussion marks considerable progress towards the application deadline in January 2025.

EU Europe
See All